Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2009 1
2012 1
2020 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Increased susceptibility to juvenile myelomonocytic leukemia"
Page 1
Juvenile xanthogranuloma in Noonan syndrome.
Ali MM, Gilliam AE, Ruben BS, Tidyman WE, Rauen KA. Ali MM, et al. Am J Med Genet A. 2021 Oct;185(10):3048-3052. doi: 10.1002/ajmg.a.62353. Epub 2021 May 25. Am J Med Genet A. 2021. PMID: 34032360 Free PMC article.
Juvenile xanthogranuloma (JXG) is an uncommon, proliferative, self-limited cutaneous disorder that affects young individuals and may be overlooked or misdiagnosed due to its transient nature. A RASopathy that is known to be associated with JXG is neurofibromatosis type 1 ( …
Juvenile xanthogranuloma (JXG) is an uncommon, proliferative, self-limited cutaneous disorder that affects young individuals and may …
Malignant diseases in Noonan syndrome and related disorders.
Hasle H. Hasle H. Horm Res. 2009 Dec;72 Suppl 2:8-14. doi: 10.1159/000243773. Epub 2009 Dec 22. Horm Res. 2009. PMID: 20029231 Review.
There are few data on cancer in adults with NS, but the reported numbers of malignancies in adults do not seem excessive. Juvenile myelomonocytic leukemia (JMML) is a rare aggressive leukemia in young children. ...The disorder often regresses spontaneo …
There are few data on cancer in adults with NS, but the reported numbers of malignancies in adults do not seem excessive. Juvenile …
Distinctive phenotypes in two children with novel germline RUNX1 mutations - one with myeloid malignancy and increased fetal hemoglobin.
Bagla S, Regling KA, Wakeling EN, Gadgeel M, Buck S, Zaidi AU, Flore LA, Chicka M, Schiffer CA, Chitlur MB, Ravindranath Y. Bagla S, et al. Pediatr Hematol Oncol. 2021 Feb;38(1):65-79. doi: 10.1080/08880018.2020.1814463. Epub 2020 Sep 29. Pediatr Hematol Oncol. 2021. PMID: 32990483
The daughter, age 13 years, presented with features resembling juvenile myelomonocytic leukemia - severe anemia, thrombocytopenia, high white cell count with blast cells, monocytosis, increased nucleated red cells and had somatic mutations with high al …
The daughter, age 13 years, presented with features resembling juvenile myelomonocytic leukemia - severe anemia, thromb …
Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disorders.
Miles DK, Freedman MH, Stephens K, Pallavicini M, Sievers EL, Weaver M, Grunberger T, Thompson P, Shannon KM. Miles DK, et al. Blood. 1996 Dec 1;88(11):4314-20. Blood. 1996. PMID: 8943868 Free article.
Children with neurofibromatosis type 1 (NF1) are at increased risk of developing malignant myeloid disorders, particularly juvenile chronic myelogenous leukemia/juvenile myelomonocytic leukemia (JCML/JMML). ...In our series and in the lit …
Children with neurofibromatosis type 1 (NF1) are at increased risk of developing malignant myeloid disorders, particularly juvenil …
Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?
Alkindy A, Chuzhanova N, Kini U, Cooper DN, Upadhyaya M. Alkindy A, et al. Hum Genomics. 2012 Aug 13;6(1):12. doi: 10.1186/1479-7364-6-12. Hum Genomics. 2012. PMID: 23244495 Free PMC article.
Neurofibromatosis type 1 (NF1) is a complex neurocutaneous disorder with an increased susceptibility to develop both benign and malignant tumors but with a wide spectrum of inter and intrafamilial clinical variability. ...Each patient was assessed for ten NF1-relate …
Neurofibromatosis type 1 (NF1) is a complex neurocutaneous disorder with an increased susceptibility to develop both benign an …